Tin tức & Cập nhật

Chỉ hiển thị Multimedia
5-ASA use in paediatric CD common, deviates from recommended practices

5-ASA use in paediatric CD common, deviates from recommended practices

07 Feb 2023 bởiJairia Dela Cruz

Children with Crohn’s disease (CD) are often treated with 5-aminosalicylate (5-ASA) contrary to guidelines, and this practice is associated with a substantial delay in initiating biologic therapy, according to a study presented at this year’s Crohn's & Colitis Congress.

5-ASA use in paediatric CD common, deviates from recommended practices

07 Feb 2023
Radiation therapy may raise colorectal cancer risk among Hodgkin's lymphoma survivors

Radiation therapy may raise colorectal cancer risk among Hodgkin's lymphoma survivors

06 Feb 2023
Isolated anti-HBc positivity ups liver-related death risk

Isolated anti-HBc positivity ups liver-related death risk

06 Feb 2023

Isolated hepatitis B core antibody (anti-HBc) positivity appears to increase the risk of liver-related and liver cancer mortality, particularly when accompanied by a high fibrosis score, according to a study of Korean adults.

Isolated anti-HBc positivity ups liver-related death risk

06 Feb 2023
Prebiotic supplementation beneficial in mild to moderate ulcerative colitis

Prebiotic supplementation beneficial in mild to moderate ulcerative colitis

03 Feb 2023
Add-on bevacizumab ups hypertension risk in CRC patients

Add-on bevacizumab ups hypertension risk in CRC patients

03 Feb 2023 bởiStephen Padilla

The addition of bevacizumab (BVZ) to the standard regimen for the treatment of advanced colorectal cancer (CRC) appears to increase the risk of cardiovascular events, suggest the results of a meta-analysis presented at the recent ASCO Gastrointestinal Cancers Symposium (ASCO GI 2023).

Add-on bevacizumab ups hypertension risk in CRC patients

03 Feb 2023
Palliative RT relieves pain in end-stage liver cancer

Palliative RT relieves pain in end-stage liver cancer

02 Feb 2023